Lung Abnormalities Persist 3 Years After Severe COVID-19
Jul 18, 2025 · More than half of severe COVID-19 survivors show fibrotic-like lung abnormalities even 3 years after infection, especially those who are more critically ill.
Risk Score Validated to Predict Lung Disease in RA - Medscape
Nov 26, 2025 · A recent study validates that combining genetic and clinical data can predict the risk for pulmonary fibrosis in patients with rheumatoid arthritis more effectively than either …
Brensocatib’s Benefits Extend to Lung Structure - Medscape
Brensocatib, newly approved by the FDA for noncystic fibrosis bronchiectasis (NCFB), was also associated with improvements in lung structure, on the basis of data from a substudy of 100 ...
EMA OKs First Therapy for Non-Cystic Fibrosis Bronchiectasis
Oct 17, 2025 · The European Medicines Agency (EMA) has recommended granting marketing authorization in the EU for brensocatib (Brinsupri, Insmed Incorporated) for non- cystic fibrosis …
ILD in Rheumatology: Screening, Treating, Monitoring - Medscape
Mar 6, 2025 · An expert in connective tissue disease–associated interstitial lung disease described best approaches for rheumatologists to be proactive in screening, diagnosing, …
FDA Approves New Option for NCFB - Medscape
Aug 22, 2025 · The FDA has approved brensocatib tablets in 10-mg and 25-mg doses as once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and children aged 12 …
Idiopathic Pulmonary Fibrosis: 5 Things to Know - Medscape
Jan 11, 2019 · The authors concluded that patients with traction bronchiectasis and possible UIP on HRCT have the same response to nintedanib as those with honeycombing on HRCT or …
Leflunomide, HCQ Combo Effects Validated in Sjögren Disease
Jun 18, 2025 · The combination of leflunomide and hydroxychloroquine outperformed placebo in reducing disease activity in primary Sjögren syndrome in a second phase II study.
The Hospital-at-Home: Managing Complex Patients From Afar
Hospital-level care at home was gaining traction even before the COVID pandemic, and for good reason: A study published in December 2019 in Annals of Internal Medicine showed that …
Non-Opioid Pain Med Gains Traction - Medscape
Dec 26, 2025 · Despite a surge in prescriptions for the non-opioid pain drug suzetrigine, clinicians are still sorting out who benefits the most and when.